If contrasting effects can be confirmed between OC and its normal counterparts, the therapeutic value of ARL6IP5 increases because of its potential to selectively trigger cell-death on cancer cells while protecting normal cells; therefore, further studies are needed to confirm the full value of ARL6IP5 as a potential therapeutic agent. This evidence concerns the gene ARL6IP5 and cancer.